Hilal Acidereli

2PUBLICATIONS
4CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 29, 2021
Acetylation of interferon regulatory factor-5 suppresses androgen receptor and downregulates expression of Sox2.

Hilal Acidereli, Fatma Aysun Turut, Ozge Cevik

|Jun 25, 2020
Cabazitaxel exhibits more favorable molecular changes compared to other taxanes in androgen-independent prostate cancer cells.

Ozge Cevik, Hilal Acidereli, Fatma Aysun Turut

Pageof 1

Frequent Collaborators

2 joint publications

Ozge Cevik

2 joint publications

Fatma Aysun Turut

1 joint publications

Sahin Yildirim

1 joint publications

Ceyda Acilan